These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 37443026)

  • 21. Impact that the COVID-19 pandemic on routine childhood vaccinations and challenges ahead: A narrative review.
    Chiappini E; Parigi S; Galli L; Licari A; Brambilla I; Angela Tosca M; Ciprandi G; Marseglia G
    Acta Paediatr; 2021 Sep; 110(9):2529-2535. PubMed ID: 34028088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers and Facilitators Associated With Vaccine Acceptance and Uptake Among Pregnant Women in High Income Countries: A Mini-Review.
    Qiu X; Bailey H; Thorne C
    Front Immunol; 2021; 12():626717. PubMed ID: 33981298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic.
    Olusanya OA; Bednarczyk RA; Davis RL; Shaban-Nejad A
    Front Immunol; 2021; 12():663074. PubMed ID: 33815424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019.
    Tessier E; Campbell H; Ribeiro S; Andrews N; Stowe J; Nicholls M; Morgan J; Litt D; Fry NK; Amirthalingam G
    Euro Surveill; 2021 Mar; 26(12):. PubMed ID: 33769247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: A test-negative case-control study in Japan.
    Ohfuji S; Okada K; Mouri Y; Mihara Y; Ishii S; Miyata A; Fujino M; Motomura C; Ito H; Ohta M; Kasahara Y; Nakamura H; Hasui M; Yoshikawa T; Tanaka T; Nakano T; Koshida R; Araki K; Hara M; Hirota Y
    Vaccine; 2021 Jan; 39(1):11-17. PubMed ID: 33229109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timeliness of DTaP-IPV-Hib Vaccination and Development of Atopic Dermatitis Between 4 Months and 1 Year of Age-Register-Based Cohort Study.
    Gehrt L; Rieckmann A; Kiraly N; Jensen AKG; Aaby P; Benn CS; Sørup S
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1520-1528.e8. PubMed ID: 33011301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of COVID-19 on Immunization Services for Maternal and Infant Vaccines: Results of a Survey Conducted by Imprint-The Immunising Pregnant Women and Infants Network.
    Saso A; Skirrow H; Kampmann B
    Vaccines (Basel); 2020 Sep; 8(3):. PubMed ID: 32972015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collateral effects of Covid-19 pandemic emergency response on worldwide immunizations.
    Torner N
    Vacunas; 2020; 21(2):73-75. PubMed ID: 32840247
    [No Abstract]   [Full Text] [Related]  

  • 29. Routine vaccination during covid-19 pandemic response.
    Saxena S; Skirrow H; Bedford H
    BMJ; 2020 Jun; 369():m2392. PubMed ID: 32546575
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review.
    Vygen-Bonnet S; Hellenbrand W; Garbe E; von Kries R; Bogdan C; Heininger U; Röbl-Mathieu M; Harder T
    BMC Infect Dis; 2020 Feb; 20(1):136. PubMed ID: 32054444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba, Canada, 1992-2015: A Canadian Immunization Research Network Study.
    Wilkinson K; Righolt CH; Kwong JC; Schwartz KL; Russell ML; Crowcroft NS; Mahmud SM
    Vaccine; 2019 Nov; 37(48):7132-7137. PubMed ID: 31564453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acellular Pertussis Vaccine Effectiveness Over Time.
    Zerbo O; Bartlett J; Goddard K; Fireman B; Lewis E; Klein NP
    Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31182549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination timeliness and delay in low- and middle-income countries: a systematic review of the literature, 2007-2017.
    Masters NB; Wagner AL; Boulton ML
    Hum Vaccin Immunother; 2019; 15(12):2790-2805. PubMed ID: 31070992
    [No Abstract]   [Full Text] [Related]  

  • 34. The effectiveness of maternal pertussis vaccination in protecting newborn infants in Brazil: A case-control study.
    Fernandes EG; Sato APS; Vaz-de-Lima LRA; Rodrigues M; Leite D; de Brito CA; Luna EJA; Carvalhanas TRMP; Ramos MLBN; Sato HK; de Castilho EA;
    Vaccine; 2019 Aug; 37(36):5481-5484. PubMed ID: 30948222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.
    Barug D; Pronk I; van Houten MA; Versteegh FGA; Knol MJ; van de Kassteele J; Berbers GAM; Sanders EAM; Rots NY
    Lancet Infect Dis; 2019 Apr; 19(4):392-401. PubMed ID: 30938299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal Vaccination in Argentina: Tetanus, Diphtheria, and Acellular Pertussis Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants <2 Months of Age.
    Romanin V; Acosta AM; Juarez MDV; Briere E; Sanchez SM; Cordoba BL; Sevilla ME; Lucion MF; Urrutia A; Sagradini S; Skoff TH; Vizzotti C
    Clin Infect Dis; 2020 Jan; 70(3):380-387. PubMed ID: 30877308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timeliness and completeness of routine childhood vaccinations in young children residing in a district with recurrent vaccine-preventable disease outbreaks, Jerusalem, Israel.
    Stein-Zamir C; Israeli A
    Euro Surveill; 2019 Feb; 24(6):. PubMed ID: 30755293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A big pertussis outbreak in a primary school with high vaccination coverage in northern China: An evidence of the emerging of the disease in China.
    Huang H; Gao P; Gao Z; Wang L; Hao B; Liu Y; Yang A; Liu P; Guo L; Zhang Y
    Vaccine; 2018 Dec; 36(52):7950-7955. PubMed ID: 30420118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study.
    Saul N; Wang K; Bag S; Baldwin H; Alexander K; Chandra M; Thomas J; Quinn H; Sheppeard V; Conaty S
    Vaccine; 2018 Mar; 36(14):1887-1892. PubMed ID: 29501321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.
    Skoff TH; Blain AE; Watt J; Scherzinger K; McMahon M; Zansky SM; Kudish K; Cieslak PR; Lewis M; Shang N; Martin SW
    Clin Infect Dis; 2017 Nov; 65(12):1977-1983. PubMed ID: 29028938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.